Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Co-Founder and CEO, Jason Kelly, is